ReviewDrugs & aging2026
Vitamin D and Older Adults: To Supplement or Not to Supplement?
Review in Drugs & aging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The 2024 Endocrine Society Guideline on Vitamin D: Comprehensive Summary and Critical Appraisal.Nutrients · 2026Pooled it
- Updated perspectives on vitamin D deficiency, screening, supplementation and clinical guidance.Cardiovascular diabetology. Endocrinology reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The aging population is steadily increasing, representing a significant portion of the global population. Vitamin D deficiency is highly prevalent, particularly among older adults and has been implicated in the pathogenesis of various chronic diseases. In June 2024, a clinical practice guideline was published by the Endocrine Society, recommending empiric vitamin D supplementation for those over 75 years old, suggesting that it could reduce mortality in this age group. Meanwhile, for the general population aged 50-74 years, not only was empiric supplementation not suggested but neither was routine testing of vitamin D levels. This review discusses the pathophysiological changes associated with aging, the conditions commonly affecting older adults that may be positively impacted by vitamin D, and the potential negative effects of such supplementation. By examining the current knowledge in the field, we aim to provide practical insights into the effects of vitamin D in individuals older than 75 years and to explore the potential benefits of expanding supplementation to include younger older adults, specifically those aged 65-74 years.
Identifiers
41579305What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.